Hobisch A - Search Results

1

Culig Z, Klocker H, Bartsch G, Hobisch A. Culig Z, et al. Among authors: hobisch a. Endocr Relat Cancer. 2002 Sep;9(3):155-70. doi: 10.1677/erc.0.0090155. Endocr Relat Cancer. 2002. PMID: 12237244 Review.

2

Acquisition of agonistic properties of nonsteroidal antiandrogens after treatment with oncostatin M in prostate cancer cells.

Godoy-Tundidor S, Hobisch A, Pfeil K, Bartsch G, Culig Z. Godoy-Tundidor S, et al. Among authors: hobisch a. Clin Cancer Res. 2002 Jul;8(7):2356-61. Clin Cancer Res. 2002. PMID: 12114440

3

Interleukin-6 regulates androgen receptor activity and prostate cancer cell growth.

Culig Z, Bartsch G, Hobisch A. Culig Z, et al. Among authors: hobisch a. Mol Cell Endocrinol. 2002 Nov 29;197(1-2):231-8. doi: 10.1016/s0303-7207(02)00263-0. Mol Cell Endocrinol. 2002. PMID: 12431817 Review.

4

The transcriptional co-activator cAMP response element-binding protein-binding protein is expressed in prostate cancer and enhances androgen- and anti-androgen-induced androgen receptor function.

Comuzzi B, Lambrinidis L, Rogatsch H, Godoy-Tundidor S, Knezevic N, Krhen I, Marekovic Z, Bartsch G, Klocker H, Hobisch A, Culig Z. Comuzzi B, et al. Among authors: hobisch a. Am J Pathol. 2003 Jan;162(1):233-41. doi: 10.1016/S0002-9440(10)63814-X. Am J Pathol. 2003. PMID: 12507906 Free PMC article.

5

Studies on androgen receptor mutations and amplification in human prostate cancer.

Culig Z, Hobisch A, Erdel M, Bartsch G, Klocker H. Culig Z, et al. Among authors: hobisch a. Methods Mol Med. 2003;81:267-75. doi: 10.1385/1-59259-372-0:267. Methods Mol Med. 2003. PMID: 12725126 No abstract available.

6

Androgen receptors in prostate cancer.

Culig Z, Klocker H, Bartsch G, Steiner H, Hobisch A. Culig Z, et al. Among authors: hobisch a. J Urol. 2003 Oct;170(4 Pt 1):1363-9. doi: 10.1097/01.ju.0000075099.20662.7f. J Urol. 2003. PMID: 14501770 Review.

7

Prostate cancer cells generated during intermittent androgen ablation acquire a growth advantage and exhibit changes in epidermal growth factor receptor expression.

Hobisch A, Fiechtl M, Sandahl-Sorensen B, Godoy-Tundidor S, Artner-Dworzak E, Ramoner R, Bartsch G, Culig Z. Hobisch A, et al. Prostate. 2004 Jun 1;59(4):401-8. doi: 10.1002/pros.10372. Prostate. 2004. PMID: 15065088

8

The androgen receptor co-activator CBP is up-regulated following androgen withdrawal and is highly expressed in advanced prostate cancer.

Comuzzi B, Nemes C, Schmidt S, Jasarevic Z, Lodde M, Pycha A, Bartsch G, Offner F, Culig Z, Hobisch A. Comuzzi B, et al. Among authors: hobisch a. J Pathol. 2004 Oct;204(2):159-66. doi: 10.1002/path.1609. J Pathol. 2004. PMID: 15378487

9

Expression and function of androgen receptor coactivators in prostate cancer.

Culig Z, Comuzzi B, Steiner H, Bartsch G, Hobisch A. Culig Z, et al. Among authors: hobisch a. J Steroid Biochem Mol Biol. 2004 Nov;92(4):265-71. doi: 10.1016/j.jsbmb.2004.10.003. Epub 2004 Dec 19. J Steroid Biochem Mol Biol. 2004. PMID: 15663989 Review.

10

Interleukin-6 and oncostatin M stimulation of proliferation of prostate cancer 22Rv1 cells through the signaling pathways of p38 mitogen-activated protein kinase and phosphatidylinositol 3-kinase.

Godoy-Tundidor S, Cavarretta IT, Fuchs D, Fiechtl M, Steiner H, Friedbichler K, Bartsch G, Hobisch A, Culig Z. Godoy-Tundidor S, et al. Among authors: hobisch a. Prostate. 2005 Jul 1;64(2):209-16. doi: 10.1002/pros.20235. Prostate. 2005. PMID: 15712220

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

115 results

Search Page

Filters